ゼリア新薬工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2019/02/28 | 1,887 | 1,923 | 1,867 | 1,899 | +6 | +0.3% | 89,700 |
2019/02/27 | 1,851 | 1,900 | 1,846 | 1,893 | +39 | +2.1% | 118,100 |
2019/02/26 | 1,860 | 1,865 | 1,842 | 1,854 | -9 | -0.5% | 82,600 |
2019/02/25 | 1,887 | 1,887 | 1,861 | 1,863 | -14 | -0.7% | 84,200 |
2019/02/22 | 1,893 | 1,895 | 1,862 | 1,877 | -31 | -1.6% | 105,800 |
2019/02/21 | 1,911 | 1,920 | 1,886 | 1,908 | +9 | +0.5% | 98,400 |
2019/02/20 | 1,908 | 1,912 | 1,892 | 1,899 | -11 | -0.6% | 74,500 |
2019/02/19 | 1,918 | 1,918 | 1,898 | 1,910 | -9 | -0.5% | 54,400 |
2019/02/18 | 1,934 | 1,934 | 1,905 | 1,919 | +25 | +1.3% | 68,000 |
2019/02/15 | 1,915 | 1,916 | 1,880 | 1,894 | -21 | -1.1% | 56,300 |
2019/02/14 | 1,915 | 1,928 | 1,906 | 1,915 | ±0 | ±0% | 76,600 |
2019/02/13 | 1,935 | 1,946 | 1,913 | 1,915 | -10 | -0.5% | 56,600 |
2019/02/12 | 1,908 | 1,926 | 1,901 | 1,925 | +25 | +1.3% | 63,300 |
2019/02/08 | 1,889 | 1,903 | 1,860 | 1,900 | -6 | -0.3% | 181,200 |
2019/02/07 | 1,920 | 1,920 | 1,893 | 1,906 | -14 | -0.7% | 128,000 |
2019/02/06 | 1,941 | 2,025 | 1,916 | 1,920 | +47 | +2.5% | 194,100 |
2019/02/05 | 1,852 | 1,899 | 1,852 | 1,873 | +25 | +1.4% | 101,900 |
2019/02/04 | 1,805 | 1,849 | 1,805 | 1,848 | +39 | +2.2% | 88,400 |
2019/02/01 | 1,805 | 1,827 | 1,801 | 1,809 | +10 | +0.6% | 81,700 |
2019/01/31 | 1,822 | 1,836 | 1,790 | 1,799 | -8 | -0.4% | 208,100 |
2019/01/30 | 1,831 | 1,841 | 1,803 | 1,807 | -34 | -1.8% | 151,700 |
2019/01/29 | 1,828 | 1,843 | 1,802 | 1,841 | +5 | +0.3% | 116,700 |
2019/01/28 | 1,845 | 1,854 | 1,823 | 1,836 | -10 | -0.5% | 95,400 |
2019/01/25 | 1,869 | 1,883 | 1,842 | 1,846 | -17 | -0.9% | 108,300 |
2019/01/24 | 1,892 | 1,892 | 1,858 | 1,863 | -40 | -2.1% | 129,400 |
2019/01/23 | 1,931 | 1,931 | 1,898 | 1,903 | -50 | -2.6% | 91,900 |
2019/01/22 | 1,973 | 1,983 | 1,946 | 1,953 | -1 | -0.1% | 114,500 |
2019/01/21 | 1,949 | 1,970 | 1,940 | 1,954 | +5 | +0.3% | 97,800 |
2019/01/18 | 1,943 | 1,967 | 1,925 | 1,949 | +4 | +0.2% | 67,700 |
2019/01/17 | 1,929 | 1,947 | 1,902 | 1,945 | +17 | +0.9% | 139,700 |
2019/01/16 | 1,938 | 1,960 | 1,917 | 1,928 | -4 | -0.2% | 117,000 |
2019/01/15 | 1,928 | 1,936 | 1,895 | 1,932 | -9 | -0.5% | 148,000 |
2019/01/11 | 1,945 | 1,948 | 1,925 | 1,941 | ±0 | ±0% | 107,000 |
2019/01/10 | 1,955 | 1,971 | 1,937 | 1,941 | -15 | -0.8% | 103,400 |
2019/01/09 | 1,957 | 1,978 | 1,943 | 1,956 | +5 | +0.3% | 103,900 |
2019/01/08 | 1,953 | 1,955 | 1,921 | 1,951 | +2 | +0.1% | 162,700 |
2019/01/07 | 2,000 | 2,000 | 1,935 | 1,949 | +20 | +1% | 101,900 |
2019/01/04 | 1,933 | 1,944 | 1,895 | 1,929 | -44 | -2.2% | 118,200 |
2018/12/28 | 1,980 | 1,991 | 1,960 | 1,973 | -2 | -0.1% | 70,100 |
2018/12/27 | 1,927 | 1,988 | 1,923 | 1,975 | +94 | +5% | 121,400 |
2018/12/26 | 1,883 | 1,929 | 1,865 | 1,881 | +2 | +0.1% | 125,200 |
2018/12/25 | 1,936 | 1,936 | 1,859 | 1,879 | -97 | -4.9% | 172,400 |
2018/12/21 | 1,967 | 1,985 | 1,928 | 1,976 | +17 | +0.9% | 212,400 |
2018/12/20 | 2,005 | 2,014 | 1,945 | 1,959 | -45 | -2.2% | 213,000 |
2018/12/19 | 1,997 | 2,023 | 1,985 | 2,004 | +7 | +0.4% | 170,200 |
2018/12/18 | 2,000 | 2,010 | 1,992 | 1,997 | -11 | -0.5% | 199,600 |
2018/12/17 | 2,012 | 2,021 | 1,990 | 2,008 | ±0 | ±0% | 145,300 |
2018/12/14 | 1,999 | 2,031 | 1,993 | 2,008 | -6 | -0.3% | 123,100 |
2018/12/13 | 2,037 | 2,039 | 2,007 | 2,014 | -6 | -0.3% | 75,000 |
2018/12/12 | 1,963 | 2,027 | 1,963 | 2,020 | +76 | +3.9% | 108,400 |
1401~
1450
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ゼリア新薬 | 225,300円 | +13.6% | +29.2% | 2.04% | 11.69倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
鳥居薬 | 478,500円 | +12.0% | +28.1% | 2.51% | 26.38倍 | 1.12倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
持田薬 | 332,500円 | +3.0% | +27.5% | 2.41% | 21.05倍 | 0.91倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
ネクセラファーマ | 115,600円 | +197.7% | - | 0.00% | 47.24倍 | 1.51倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
杏林製薬 | 150,500円 | +3.2% | +4.5% | 3.46% | 17.29倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム